Nobel Prize-winning economist Joseph Stiglitz has reiterated his opposition to the Trans Pacific Partnership (TPP), saying on August 23 that United States President Barack Obama’s push to get the trade deal passed during the upcoming lame-duck session of Congress is “outrageous” and “absolutely wrong”.
The TPP is a huge proposed trade deal involving 12 Pacific Rim nations, including Australia. It encompasses 40% of the world’s GDP. It was negotiated in secret, but draft chapters published by WikiLeaks confirmed anti-TPP campaigners’ worst fears of a huge power grab by corporations.
Trans Pacific Partnership
The media and advocates of the proposed Trans-Pacific Partnership (TPP) trade agreement have repeatedly described opponents of the deal as opposed to trade itself.
For instance, after US Republican presidential candidate Donald Trump pressed his Democrat rival Hillary Clinton to swear off passage of the deal, the New York Times said Trump was embracing “nationalistic anti-trade policies”.
The Wall Street Journal said Trump expressed “protectionist views”. US President Barack Obama warned that you cannot withdraw “from trade deals” and focus “solely on your local market”.

The Trans-Pacific Partnership (TPP) agreement, which involves 12 Pacific rim nations, seriously threatens indigenous land rights, as well as the natural resources they preserve, said United Nations Special Rapporteur on the Rights of Indigenous Peoples Victoria Tauli-Corpuz.
In an interview with the International Work Group for Indigenous Affairs, Tauli-Corpuz said a major issue with the trade deal is “the clause of non-discrimination between a local and an international investor ... [it] grants more rights to transnational firms, often at the expense of indigenous rights”.


WikiLeaks released the secret draft of the healthcare annex to the transparency chapter of the Trans-Pacific Partnership (TPP) on June 10. If the TPP is adopted, the annex would adversely affect national pharmaceutical schemes, such as Australia's Pharmaceutical Benefits Scheme and New Zealand's Pharmaceutical Management Agency (PHARMAC).
The TPP is a free trade deal being negotiated by countries on the Pacific rim: the US, Australia, Singapore, New Zealand, Chile, Brunei, Canada, Malaysia, Mexico, Peru, Vietnam and Japan. These countries represent about 40% of global GDP.

A report has found that the Trans-Pacific Partnership (TPP) agreement would be likely to adversely affect the health of the Australian population.
The TPP is a free trade deal being negotiated by countries on the Pacific rim: the US, Australia, Singapore, New Zealand, Chile, Brunei, Canada, Malaysia, Mexico, Peru, Vietnam and Japan. These countries represent about 40% of global GDP.
